Skip to content

UroGen Pharma Ltd.: 10-Q filed 2022-11-10

What UroGen Pharma Ltd. reported in its quarterly report filed 2022-11-10 (fiscal Q3 2022): 41 published measures, 111 facts as tagged in accession 0001437749-22-026727.

This filing

Form
10-Q (quarterly report)
Filed
2022-11-10
Fiscal period
fiscal Q3 2022
Accession
0001437749-22-026727 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All UroGen Pharma Ltd. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-30128,473,000USD
At 2021-12-31119,746,000USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-30191,759,000USD
At 2021-12-31111,333,000USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-30-63,286,000USD
At 2022-06-30-40,913,000USD
At 2021-12-318,413,000USD
At 2021-09-3031,537,000USD
At 2021-06-3056,271,000USD
At 2020-12-3196,355,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-09-3028,686,000USD
At 2021-12-3144,360,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-25,831,000USD92
2022-01-01 to 2022-09-30-80,914,000USD273
2021-07-01 to 2021-09-30-30,211,000USD92
2021-01-01 to 2021-09-30-82,368,000USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-65,807,000USD273
2021-01-01 to 2021-09-30-64,822,000USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-09-30241,000USD273
2021-01-01 to 2021-09-30550,000USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2022-07-01 to 2022-09-3016,097,000USD92
2022-01-01 to 2022-09-3046,265,000USD273
2021-07-01 to 2021-09-3011,351,000USD92
2021-01-01 to 2021-09-3031,868,000USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-09-3071,766,000USD273
2021-01-01 to 2021-09-3072,351,000USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-22,048,000USD273
2021-01-01 to 2021-09-30-5,056,000USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-30-548,235,000USD
At 2021-12-31-467,321,000USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-07-01 to 2022-09-3022,798,263shares92
2022-01-01 to 2022-09-3022,711,686shares273
2021-07-01 to 2021-09-3022,380,598shares92
2021-01-01 to 2021-09-3022,318,589shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-1.13USD/shares92
2022-01-01 to 2022-09-30-3.56USD/shares273
2021-07-01 to 2021-09-30-1.35USD/shares92
2021-01-01 to 2021-09-30-3.69USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2022-07-01 to 2022-09-30709,000USD92
2022-01-01 to 2022-09-301,066,000USD273
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-30312,000USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-09-301,519,000USD
At 2021-12-311,967,000USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-09-308,212,000USD273
2021-01-01 to 2021-09-3017,756,000USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-18,087,000USD92
2022-01-01 to 2022-09-30-58,759,000USD273
2021-07-01 to 2021-09-30-23,440,000USD92
2021-01-01 to 2021-09-30-72,377,000USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-09-30121,594,000USD
At 2021-12-31114,390,000USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-3018,999,000USD
At 2021-12-3122,380,000USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-09-302,545,000USD
At 2021-12-315,786,000USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-09-309,429,000USD
At 2021-12-3111,717,000USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2022-09-304,862,000USD
At 2021-12-314,832,000USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-3014,077,000USD92
2022-01-01 to 2022-09-3040,874,000USD273
2021-07-01 to 2021-09-3010,107,000USD92
2021-01-01 to 2021-09-3028,300,000USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2022-07-01 to 2022-09-302,020,000USD92
2022-01-01 to 2022-09-305,391,000USD273
2021-07-01 to 2021-09-301,244,000USD92
2021-01-01 to 2021-09-303,568,000USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2022-07-01 to 2022-09-3019,071,000USD92
2022-01-01 to 2022-09-3061,204,000USD273
2021-07-01 to 2021-09-3021,624,000USD92
2021-01-01 to 2021-09-3066,117,000USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-07-01 to 2022-09-3013,093,000USD92
2022-01-01 to 2022-09-3038,429,000USD273
2021-07-01 to 2021-09-3011,923,000USD92
2021-01-01 to 2021-09-3034,560,000USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-09-3023,011,324shares
At 2021-12-3122,462,995shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2022-09-30-155,000USD
At 2021-12-31-25,000USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-09-302,666,000USD
At 2021-12-311,180,000USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2022-09-302,796,000USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2022-09-304,433,000USD
At 2021-12-314,193,000USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2022-09-302,914,000USD
At 2021-12-312,226,000USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2022-09-302,471,000USD
At 2021-12-311,311,000USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-09-3010,580,000USD
At 2021-12-317,476,000USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-25,122,000USD92
2022-01-01 to 2022-09-30-79,848,000USD273
2021-07-01 to 2021-09-30-30,211,000USD92
2021-01-01 to 2021-09-30-82,056,000USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-25,930,000USD92
2022-01-01 to 2022-09-30-81,044,000USD273
2021-07-01 to 2021-09-30-30,252,000USD92
2021-01-01 to 2021-09-30-82,635,000USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-07-01 to 2022-09-30200,000USD92
2022-01-01 to 2022-09-30688,000USD273
2021-07-01 to 2021-09-30200,000USD92
2021-01-01 to 2021-09-30618,000USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-01-01 to 2022-09-30135,000USD273
2021-01-01 to 2021-09-30-76,000USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2022-01-01 to 2022-09-303,926,000USD273
2021-01-01 to 2021-09-302,734,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-2,288,000USD273
2021-01-01 to 2021-09-30737,000USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30645,000USD273
2021-01-01 to 2021-09-301,844,000USD273

Inspect the source

Entity
UroGen Pharma Ltd. / CIK 0001668243
Captured
2026-09-21T17:22:34.317Z
SEC response SHA-256
c0f9fceebc685f0377739af490e9f9cff0a1b4a6e8cf3110d6b22e5d217158cf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001668243.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))